OrsoBio Funding & Investors
OrsoBio is a clinical-stage biopharmaceutical company that creates therapies for patients suffering from severe metabolic disorders such as diabetes, severe dyslipidemia, lipodystrophies, and others. OrsoBio is committed to restoring energy homeostasis in patients with severe metabolic disorders, in some cases, by targeting pathways relevant to maintaining energy balance. OrsoBio revolutionizes the treatment of these disorders by addressing the underlying cause.
orsobio.comTotal Amount Raised: $62,300,000
OrsoBio Funding Rounds
Series A
$60,000,000
Series A Investors
Enavate SciencesEli LillyLongitude CapitalSamsara BioCapitalNuevaBioGrant
$2,300,000
Grant Investors
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Funding info provided by Diffbot.